건초염 치료제 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 원격 의료 서비스의 확대, 글로벌 보건 이니셔티브, 근골격계 질환의 유병률 증가, 건초염 치료제 수요 증가, 만성 질환의 유병률의 상승에 기인하고 있습니다. 주요 발전 동향으로서는 수술 기법의 발전, 수술에 있어서의 로봇 공학의 통합, 저침습 수술의 진보, 나노 테크놀로지의 혁신, 약제 제제의 개발 등을 들 수 있습니다.
근골격계 질환의 유병률 증가는 건초염 치료제 시장의 성장을 크게 촉진할 것으로 예측됩니다. 인구 고령화, 좌식 생활 방식, 직업적 위험 증가 등의 요인이 이러한 장애의 유병률 증가에 기여하고 있습니다. Health Improvement and Disparities 사무소가 보고한 바에 따르면 영국에서는 16세 이상의 17.6%가 장기의 근골격계 질환을 갖고 있으며, 2021년 17.0%에서 증가한 수치입니다.
스포츠 부상 발생률 증가는 또한 건초염 치료제 시장에서 효과적인 치료제 수요를 촉진합니다. 끊임없는 기술, 충돌로 인한 건초염 치료제는 통증과 부종을 완화하고 회복을 가속화하고 운동 능력을 향상시킴으로써 이러한 상해를 치료하는 데 사용됩니다. Howden Group Holdings Ltd.가 2023년 11월에 발표한 보고서에서는 FIFA 월드컵 카타르 2022 개최 후 발목 부상이 170% 증가, 종아리 및 정강이 부상이 200% 증가, 햄스트링의 부상이 130% 증가하는 등, 잉글랜드 프리미어 리그에서 스포츠 부상의 대폭적인 급증이 강조되고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 건초염 치료제 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계의 건초염 치료제 시장 : 성장률 분석
- 세계의 건초염 치료제 시장 실적 : 규모와 성장, 2019-2024
- 세계의 건초염 치료제 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계의 건초염 치료제 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 건초염 치료제 시장 : 약제유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 비스테로이드성 항염증제(NSAID)
- 코르티코스테로이드
- 항생제
- 기타 약물의 유형
- 세계의 건초염 치료제 시장 : 적응증별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 도켈반 건염
- 협착성 건염
- 트리거 핑거
- 기타 적응증
- 세계의 건초염 치료제 시장 : 투여 경로별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 오랄
- 주사제
- 주제
- 세계의 건초염 치료제 시장 : 유통 채널별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 병원 약국
- 소매 약국
- 온라인 약국
- 세계의 건초염 치료제 시장 : 비스테로이드성 항염증제(NSAIDs)유형별 하위 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 이부프로펜
- 나프록센
- 디클로페낙
- 셀레콕시브
- 세계의 건초염 치료제 시장 : 코르티코스테로이드유형별 하위 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 프레드니손
- 메틸프레드니솔론
- 덱사메타손
- 트리암시놀론
- 세계의 건초염 치료제 시장 : 항생제유형별 하위 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 페니실린
- 세팔로스포린
- 플루오로퀴놀론
- 마크로라이드
- 세계의 건초염 치료제 시장 : 기타 약제 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 질환 수식성 항류마티스약(DMARD)
- 생물학적 제형
- 진통제
제7장 지역별/국가별 분석
- 세계의 건초염 치료제 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 건초염 치료제 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 건초염 치료제 시장 : 경쟁 구도
- 건초염 치료제 시장 : 기업 프로파일
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
- AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
- GSK plc
- Takeda Pharmaceutical Company Limited
- Eli Lilly and Company
- Amgen Inc.
- Teva Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Perrigo Company plc
- Cipla Limited
- Dr. Reddy's Laboratories Ltd.
- Aurobindo Pharma Limited
- Endo International plc
- Lupin Limited
- Mallinckrodt Pharmaceuticals
- Zydus Cadila Healthcare
- AdvaCare Pharma
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 건초염 치료제 시장 2029 : 새로운 기회를 제공하는 국가
- 건초염 치료제 시장 2029 : 새로운 기회를 제공하는 부문
- 건초염 치료제 시장 2029 : 성장 전략
제36장 부록
SHW
Tenosynovitis drugs are medications used to alleviate inflammation, pain, and swelling in the tendon sheath caused by conditions such as infection, overuse, or autoimmune diseases. Treatment options typically include nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and antibiotics for infectious cases. In severe or chronic inflammatory forms, disease-modifying antirheumatic drugs (DMARDs) or biologics may be prescribed.
The main drug types in the tenosynovitis drug market include NSAIDs, corticosteroids, antibiotics, and other medications. NSAIDs are commonly used to reduce pain and inflammation without steroids, helping manage tenosynovitis symptoms such as swelling and discomfort. These drugs are indicated for conditions such as De Quervain tenosynovitis, stenosing tenosynovitis, and trigger finger. They are available in various administration forms, including oral, injectable, and topical, and are distributed through hospital pharmacies, retail pharmacies, and online platforms.
The tenosynovitis drugs market research report is one of a series of new reports from The Business Research Company that provides tenosynovitis drugs market statistics, including the tenosynovitis drugs industry's global market size, regional shares, competitors with a tenosynovitis drugs market share, detailed tenosynovitis drugs market segments, market trends and opportunities, and any further data you may need to thrive in the tenosynovitis drugs industry. This tenosynovitis drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The tenosynovitis drugs market size has grown strongly in recent years. It will grow from $1.19 billion in 2024 to $1.29 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth during the historic period can be attributed to the rise in sport injuries, the growing aging population, increased healthcare expenditure, greater awareness about tenosynovitis, and the increasing adoption of biologic treatments.
The tenosynovitis drugs market size is expected to see strong growth in the next few years. It will grow to $1.75 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth during the forecast period can be attributed to the expansion of telehealth services, global health initiatives, the rising prevalence of musculoskeletal disorders, growing demand for tenosynovitis drugs, and the increasing prevalence of chronic diseases. Key trends include advancements in surgical techniques, the integration of robotics in surgery, progress in minimally invasive procedures, innovations in nanotechnology, and developments in drug formulation.
The rising prevalence of musculoskeletal disorders is expected to significantly drive the growth of the tenosynovitis drugs market. Musculoskeletal disorders, which affect muscles, tendons, ligaments, nerves, and joints, cause pain and hinder movement. Factors such as aging populations, sedentary lifestyles, and increased occupational hazards contribute to the growing prevalence of these disorders. Tenosynovitis, a condition characterized by inflammation of the tendons and their sheaths, is treated with medications such as anti-inflammatory drugs and corticosteroids that reduce inflammation and alleviate pain. For example, in March 2023, the Office for Health Improvement and Disparities reported that 17.6% of individuals aged 16 and older in the UK had a long-term musculoskeletal condition, up from 17.0% in 2021. This increase in musculoskeletal conditions is contributing to the growing demand for tenosynovitis drugs.
The growing incidence of sports injuries is also fueling the demand for effective therapeutics in the tenosynovitis drugs market. Sports injuries, which can range from minor sprains to more severe fractures, often result from overuse, improper technique, or collisions during athletic activities. These injuries commonly involve tendon inflammation, and tenosynovitis drugs are used to treat them by reducing pain and swelling, thus facilitating faster recovery and improved mobility. For instance, a report by Howden Group Holdings Ltd. in November 2023 highlighted a significant surge in sports injuries in the English Premier League, including a 170% increase in ankle injuries, a 200% rise in calf/shin injuries, and a 130% increase in hamstring injuries following the FIFA World Cup Qatar 2022. The higher incidence of sports-related injuries is driving greater demand for tenosynovitis drugs.
Companies in the tenosynovitis drugs market are also innovating with advanced drug formulations to enhance treatment efficacy, minimize side effects, and improve patient adherence. For instance, in July 2024, ANI Pharmaceuticals Inc. received FDA approval for its Naproxen delayed-release tablets, which were introduced as a generic alternative to EC-Naprosyn. This formulation helps provide extended pain relief while reducing gastrointestinal irritation, making it an ideal treatment for inflammatory conditions such as tenosynovitis, tendonitis, and arthritis. These innovations in drug formulation are improving the overall treatment experience, which is expected to further drive market growth.
Major players in the tenosynovitis drugs market are Pfizer Inc., Roche Holding AG, Bayer AG, Sanofi S.A., AstraZeneca plc, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Cipla Limited, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Endo International plc, Lupin Limited, Mallinckrodt Pharmaceuticals, Zydus Cadila Healthcare, and AdvaCare Pharma.
North America was the largest region in the tenosynovitis drugs market in 2024. The regions covered in tenosynovitis drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the tenosynovitis drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The tenosynovitis drugs market includes revenues earned by prescription medications, over-the-counter (OTC) products, biologics and disease-modifying drugs, topical treatments, injections, and infusions. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Tenosynovitis Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on tenosynovitis drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for tenosynovitis drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tenosynovitis drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDS); Corticosteroids; Antibiotics; Other Drug Types
- 2) By Indication: De Quervain Tenosynovitis; Stenosing Tenosynovitis; Trigger Finger; Other Indications
- 3) By Route Of Administration: Oral; Injectable; Topical
- 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
- Subsegments:
- 1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen; Naproxen; Diclofenac; Celecoxib
- 2) By Corticosteroids: Prednisone; Methylprednisolone; Dexamethasone; Triamcinolone
- 3) By Antibiotics: Penicillins; Cephalosporins; Fluoroquinolones; Macrolides
- 4) By Other Drug Types: Disease-Modifying Anti-Rheumatic Drugs (DMARDs); Biologics; Analgesics
- Companies Mentioned: Pfizer Inc.; Roche Holding AG; Bayer AG; Sanofi S.A.; AstraZeneca plc
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Tenosynovitis Drugs Market Characteristics
3. Tenosynovitis Drugs Market Trends And Strategies
4. Tenosynovitis Drugs Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Tenosynovitis Drugs Growth Analysis And Strategic Analysis Framework
- 5.1. Global Tenosynovitis Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Tenosynovitis Drugs Market Growth Rate Analysis
- 5.4. Global Tenosynovitis Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Tenosynovitis Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Tenosynovitis Drugs Total Addressable Market (TAM)
6. Tenosynovitis Drugs Market Segmentation
- 6.1. Global Tenosynovitis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)
- Corticosteroids
- Antibiotics
- Other Drug Types
- 6.2. Global Tenosynovitis Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- De Quervain Tenosynovitis
- Stenosing Tenosynovitis
- Trigger Finger
- Other Indications
- 6.3. Global Tenosynovitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Injectable
- Topical
- 6.4. Global Tenosynovitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- 6.5. Global Tenosynovitis Drugs Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Ibuprofen
- Naproxen
- Diclofenac
- Celecoxib
- 6.6. Global Tenosynovitis Drugs Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Prednisone
- Methylprednisolone
- Dexamethasone
- Triamcinolone
- 6.7. Global Tenosynovitis Drugs Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Penicillins
- Cephalosporins
- Fluoroquinolones
- Macrolides
- 6.8. Global Tenosynovitis Drugs Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
- Biologics
- Analgesics
7. Tenosynovitis Drugs Market Regional And Country Analysis
- 7.1. Global Tenosynovitis Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Tenosynovitis Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Tenosynovitis Drugs Market
- 8.1. Asia-Pacific Tenosynovitis Drugs Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Tenosynovitis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Tenosynovitis Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Tenosynovitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Tenosynovitis Drugs Market
- 9.1. China Tenosynovitis Drugs Market Overview
- 9.2. China Tenosynovitis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Tenosynovitis Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Tenosynovitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Tenosynovitis Drugs Market
- 10.1. India Tenosynovitis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Tenosynovitis Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Tenosynovitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Tenosynovitis Drugs Market
- 11.1. Japan Tenosynovitis Drugs Market Overview
- 11.2. Japan Tenosynovitis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Tenosynovitis Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Tenosynovitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Tenosynovitis Drugs Market
- 12.1. Australia Tenosynovitis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Tenosynovitis Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Tenosynovitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Tenosynovitis Drugs Market
- 13.1. Indonesia Tenosynovitis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Tenosynovitis Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Tenosynovitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Tenosynovitis Drugs Market
- 14.1. South Korea Tenosynovitis Drugs Market Overview
- 14.2. South Korea Tenosynovitis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Tenosynovitis Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Tenosynovitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Tenosynovitis Drugs Market
- 15.1. Western Europe Tenosynovitis Drugs Market Overview
- 15.2. Western Europe Tenosynovitis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Tenosynovitis Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Tenosynovitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Tenosynovitis Drugs Market
- 16.1. UK Tenosynovitis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Tenosynovitis Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Tenosynovitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Tenosynovitis Drugs Market
- 17.1. Germany Tenosynovitis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Tenosynovitis Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Tenosynovitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Tenosynovitis Drugs Market
- 18.1. France Tenosynovitis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Tenosynovitis Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Tenosynovitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Tenosynovitis Drugs Market
- 19.1. Italy Tenosynovitis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Tenosynovitis Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Tenosynovitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Tenosynovitis Drugs Market
- 20.1. Spain Tenosynovitis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Tenosynovitis Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Tenosynovitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Tenosynovitis Drugs Market
- 21.1. Eastern Europe Tenosynovitis Drugs Market Overview
- 21.2. Eastern Europe Tenosynovitis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Tenosynovitis Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Tenosynovitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Tenosynovitis Drugs Market
- 22.1. Russia Tenosynovitis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Tenosynovitis Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Tenosynovitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Tenosynovitis Drugs Market
- 23.1. North America Tenosynovitis Drugs Market Overview
- 23.2. North America Tenosynovitis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Tenosynovitis Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Tenosynovitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Tenosynovitis Drugs Market
- 24.1. USA Tenosynovitis Drugs Market Overview
- 24.2. USA Tenosynovitis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Tenosynovitis Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Tenosynovitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Tenosynovitis Drugs Market
- 25.1. Canada Tenosynovitis Drugs Market Overview
- 25.2. Canada Tenosynovitis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Tenosynovitis Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Tenosynovitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Tenosynovitis Drugs Market
- 26.1. South America Tenosynovitis Drugs Market Overview
- 26.2. South America Tenosynovitis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Tenosynovitis Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Tenosynovitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Tenosynovitis Drugs Market
- 27.1. Brazil Tenosynovitis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Tenosynovitis Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Tenosynovitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Tenosynovitis Drugs Market
- 28.1. Middle East Tenosynovitis Drugs Market Overview
- 28.2. Middle East Tenosynovitis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Tenosynovitis Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Tenosynovitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Tenosynovitis Drugs Market
- 29.1. Africa Tenosynovitis Drugs Market Overview
- 29.2. Africa Tenosynovitis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Tenosynovitis Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Tenosynovitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Tenosynovitis Drugs Market Competitive Landscape And Company Profiles
- 30.1. Tenosynovitis Drugs Market Competitive Landscape
- 30.2. Tenosynovitis Drugs Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
31. Tenosynovitis Drugs Market Other Major And Innovative Companies
- 31.1. GSK plc
- 31.2. Takeda Pharmaceutical Company Limited
- 31.3. Eli Lilly and Company
- 31.4. Amgen Inc.
- 31.5. Teva Pharmaceutical Industries Ltd.
- 31.6. Sun Pharmaceutical Industries Ltd.
- 31.7. Perrigo Company plc
- 31.8. Cipla Limited
- 31.9. Dr. Reddy's Laboratories Ltd.
- 31.10. Aurobindo Pharma Limited
- 31.11. Endo International plc
- 31.12. Lupin Limited
- 31.13. Mallinckrodt Pharmaceuticals
- 31.14. Zydus Cadila Healthcare
- 31.15. AdvaCare Pharma
32. Global Tenosynovitis Drugs Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Tenosynovitis Drugs Market
34. Recent Developments In The Tenosynovitis Drugs Market
35. Tenosynovitis Drugs Market High Potential Countries, Segments and Strategies
- 35.1 Tenosynovitis Drugs Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Tenosynovitis Drugs Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Tenosynovitis Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
